abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
5059: Maternal Serum Afp Print View
Interpretation      
Risk of ONTD      
Calc'd Gestational Age      
AFP, Serum ICMA    ng/mL 
AFP MoM IA    MoM 
Date of Birth      
Collection Date      
Maternal Weight      
Est'd Date of Delivery      
EDD Determined by      
Mother's Ethnic Origin      
Number of Fetuses      
Insulin Depend Diabetic      
Repeat Specimen      
Hx of Neural Tube Defects      
Brief History      
Prev Pregnancy Down Synd      
Donor Egg      
Donor Age: Egg Retrieval      

PRIMARY
1 Serum 1 (0.5) mL   Room Temperature - 14 Day(s)/Refrigerated - 14 Day(s)/Frozen - 45 Day(s)  
ALTERNATE

Maternal serum alpha-fetoprotein (MSAFP) is used for prenatal screening. Maternal serum Alpha-Fetoprotein (AFP) elevation is associated with open neural tube defects, multiple gestation, placental anomalies, ventral abdominal wall defects, congenital nephrosis, and oligohydramnios. Follow-up for abnormal AFP results include genetic counseling, level II or III ultrasound examination and consideration of amniocentesis for chromosome and AFP analysis. MSAFP is not to be used as a screening test for chromosomal abnormalities.

Prenatal risk assessment for open neural tube defects (NTDs).
For manual order use Maternal Serum Screen Requisition.
The MSAFP test in pregnant women should be performed
between 15.0 and 22.9 weeks gestational age, although the optimal
period is 15.0-16.9 weeks. This time frame allows sufficient
opportunity for further diagnostic studies if the initial MSAFP
results are abnormal. Specimens submitted before 15.0 weeks
or after 22.9 weeks gestation cannot be properly evaluated.
Because MSAFP test results are influenced by certain patient
characteristics, the following data must be provided with
the specimen in order to permit accurate interpretation
of results: date of collection, patient's (maternal) date of
birth, patient's estimated date of delivery (EDD), patient's
weight (in lbs.) patient's race, patient diabetic status
(is patient insulin-dependent prior to pregnancy), number
of fetuses, and whether this is a repeat sample.
Setup Schedule
Monday-Saturday

Reported (Analytical Time)
Next day

CPT Code
82105

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
**This test is not available for California or New York patient testing. For New York patient testing, use test code 92788-Maternal Serum AFP (NY)**

Specimen Requirements: 1 mL (0.5 mL minimum) serum collected in a serum separator tube

Transport Temperature: Room temperature

Reject Criteria: Grossly lipemic

Methodology: Immunoassay






1996 - 2018 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database